baber/WOPTO huggingface dataset:
Patent NZ-254925-A (NZ)
Title: Container closure; inner screw threaded cap fits into outer cap member
Inventor: TAYLOR JULIAN DAVIDSON
IPC: B65D50/04
Filed: 1993-08-09
Abstract: A closure device for a container having a screw-threaded neck comprises an inner screw-threaded cap, and an outer cap (20) into which the inner cap fits, the outer cap (20) engaging with the inner cap for turning the latter to screw it onto the container neck but normally being free to turn in the opposite direction: the top of the inner cap has a non-circular formation (e.g. a socket) which can engage, through an opening in the top of the outer member, a complementary-shaped formation (e.g. a projection (32)) of a fixed bracket (30). The container can then be turned to unscrew the closure device from the container: the user can do this using the only one hand.
Patent NZ-278398-A (NZ)
Title: Polymeric compositions comprising 75-95% ethylene/alpha-olefin copolymer and 5-25% propylene/ethylene copolymer
Inventor: GOVONI GABRIELE
IPC: B29C48/18
Filed: 1995-01-12
Abstract: Polymeric compositions based on Linear Low Density Polyethylene (LLDPE) comprising: (A) from 75 to 95% by weight of an ethylene copolymer with an  alpha -olefin CH2=CHR, wherein R is an alkyl radical having from 1 to 10 carbon atoms, and (B) from 5 to 25% by weight of a copolymer of propylene with ethylene and an  alpha -olefin CH2=CHRI, wherein RI is an alkyl radical having from 2 to 10 carbon atoms. Copolymer (B) is characterised by a relatively high insolubility in xylene. The polymeric compositions of the invention are endowed with improved processability and improved mechanical properties with respect to the LLDPE of the conventional type.
Patent NZ-302439-A (NZ)
Title: Preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders comprises a gel or paste having cations and anions
Inventor: BOSCH WILLEM FREDERIK VAN DEN
IPC: A61K8/00
Filed: 1996-02-23
Abstract: PCT No. PCT/NL96/00091 Sec. 371 Date Sep. 5, 1997 Sec. 102(e) Date Sep. 5, 1997 PCT Filed Feb. 23, 1996 PCT Pub. No. WO96/25916 PCT Pub. Date Aug. 29, 1996The present invention relates to a method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders, in which method at least the following are combined: (a) a gel or paste in which a component (i) is present, component (i) being composed of at least a cation An+ and an anion OmX-; where A is a metal from Group 1 or 2 of the periodic system, n=1 or 2, X is a halogen atom and m=1-4, and (b) a gel or paste in which a component (ii) is present, component (ii) being composed of at least a cation An+ and an anion [BpOq]r-, where A is a metal from Group 1 or 2 of the periodic system, p=1-4, q=1-8 and r=1-3.
Patent NZ-332117-A (NZ)
Title: Enteric-coated pharmaceutical compositions of mycophenolate
Inventor: HAEBERLIN BARBARA
IPC: A61K38/00
Filed: 1997-04-10
Abstract: This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to prevent release the mycophenolate salt in the stomach and to release the mycophenolate salt in the upper part of the intestinal tract.
Patent NZ-335221-A (NZ)
Title: Simulator for loading and aiming training of mortar-type front-loaded barrel weapons
Inventor: LAZECKI RENE
IPC: F41A33/00
Filed: 1999-04-15
Abstract: A simulator for front loaded barrel weapons, such as mine or grenade launchers, includes an opening 7 at the bottom end of the launcher tube 3 to allow the shot 8 to drop out.  Of course the simulator may be provided with sensors 6, 10, 15 for detecting the aiming of the weapon so that a suitable target strike may be predicted or simulated.
Patent NZ-335682-A (NZ)
Title: System and method for broadband millimeter wave data communication
Inventor: FOSTER ROBERT B
IPC: H04W72/12
Filed: 1997-09-22
Abstract: Respective nodes 150, 151, 152 may communicate via radio signals in the millimetric wavelength (tens of gigahertz) band, using different frequencies for directional communications from respective nodes.  A processor based communications hub101 is provided with respective antennas for communication with the respective nodes on the particular frequency.  The hub antennas are switchably connected to internal signals provided from within the hub.
Patent NZ-500205-A (NZ)
Title: Common interface between applications and computer components
Inventor: SARFATI JEAN-CLAUDE
IPC: H04N7/173
Filed: 1997-04-25
Abstract: To enable an application stored in and executable on a receiver/decoder to receive a message concerning a function performed by a component of the receiver/decoder, logical devices representing a function of the receiver/decoder and being separate from the component of the receiver/decoder for performing that function, are stored in the receiver/decoder, and each assigned a respective device identifier. An application identifier is assigned to the application, and a signal comprising the application identifier and the device identifier of a logical device from which the application wishes to receive messages concerning the function of the receiver/decoder which that logical device represents is output to a device manager between the application and the or each logical device.  The device manager to creates a communication channel between said application and the logical device identified.
Patent NZ-502510-A (NZ)
Title: Hyperimmune maternal extracts for use in treating skin infections, oral infections or urogenital infections
Inventor: FOLAN MICHAEL ANTHONY
IPC: A61K35/54
Filed: 1998-07-23
Abstract: Medicaments formed from maternal immune secretion having biological activity characteristic of human saliva and other mucosal secretion and which is tolerated by humans can be used for the treatment and/or prophylaxis of conditions of the human body such as the buccal cavity characterised by a loss of normal mucosal or the normal biological properties thereof. The secretions are suitably egg fluid or milk from a domestic animal or replicas thereof. These secretions can be enriched with the native immunoglobulin found therein so that they have a potency which approximates that of hyperimmunised immunoglobulin. The medicaments have particular application in the treatment and/or prophylaxis of oral infection, dental caries, conditions of the buccal cavity characterised by inflammation, xerostomia and halitosis.
Patent NZ-503781-A (NZ)
Title: Transforming grape plant cells with vir genes to provide bacterial resistance
Inventor: PANG SHENG-ZHI
IPC: C12N15/84
Filed: 1998-10-15
Abstract: Described is a transgenic grapevine or transgenic grapevine component transformed with a vir gene or an anti-pathogenic fragment thereof.  Expression of the vir gene or the anti-pathogenic fragment thereof in the transgenic grapevine provides resistance to plant bacterial pathogens such as Agrobacterium vitis.
Patent NZ-506151-A (NZ)
Title: Self repairing cable with layer of self repairing material surrounding inner conductor
Inventor: MAUNDER ANDREW L
IPC: B29C48/06
Filed: 2000-08-07
Abstract: A power cable includes a layer 4 of self-repairing material 4.  This layer is intended to automatically form a seal if the layer is ruptured by an external force.  The self repairing layer is formed as an inclusion in insulation layer 6.  The layer  4 is not continuous in cross section, but is interrupted by ridges 5 in the insulation layer (Fig 1).  Alternatively the self-repairing layer may be completely encapsulated in the insulating layer (Fig 2).  The self repairing layer may consist of solid polymeric materials dispersed in an oily phase.  An apparatus for applying the self-repairing layer by extruding it onto the outside of a conductor is also described.
Patent NZ-513494-A (NZ)
Title: Toothbrush head with flexibly mounted bristles
Inventor: HOHLBEIN DOUGLAS J
IPC: A46B3/00
Filed: 2000-02-09
Abstract: A toothbrush (10) having bristles mounted on a flexibly resilient  lattice network, such that the  bristles  deflect during  brushing to conform to the various arcuate  surfaces of the teeth for more effective cleaning thereof.
Patent NZ-519102-A (NZ)
Title: Container formed by two chambers capable of being assembled by one of their surfaces
Inventor: FLORINO MARC
IPC: B65D8/04
Filed: 2000-11-08
Abstract: Here is disclosed a container (1) made up of two receptacles (2, 3) that can be assembled together via respective ones (6a, 6b) of their faces. The assembly face of each receptacle comprises in similar manner a transversely-extending step in the form of a groove having a bottom trough, a bottom abutment, and top abutment, such that when in the head-to-tail position, the trough of the groove of each receptacle cooperates with the edge of the groove of the other receptacle, and the bottom abutment of each receptacle cooperates with the top abutment of the other receptacle, in such a manner as to assemble the two receptacles together, blocking relative displacement between them both in the transverse and in the longitudinal directions.
Patent NZ-520124-A (NZ)
Title: Energy absorbing garment
Inventor: HASKELL THOMAS REX
IPC: A41D13/015
Filed: 2002-07-11
Abstract: An energy absorbing and /or spreading garment includes an inner layer (2), an outer layer (1), a plurality of arcuate panels (3-6) housed between the inner layer and the outer layer of the garment, but not attached to either the inner or outer layer and wherein each panel is arranged to overlap and slide relative to at least one adjacent panel to dissipate and/or absorb energy upon impact.
Patent NZ-522667-A (NZ)
Title: Quinolonecarboxylic acid derivative with high antibacterial acitivity and safety and highly stable to light and ahumidity.
Inventor: TAKEMURA MAKOTO
IPC: A61K31/4709
Filed: 2001-03-30
Abstract: The compound of formula (1) is described. Antibacterial compositions comprising the compound are useful in treating infectious diseases.
Patent NZ-522974-A (NZ)
Title: Medical device
Inventor: HJERTMAN BIRGER
IPC: A61M5/31
Filed: 2001-05-22
Abstract: An injector device for delivery of liquid from a high pressure source, and also a method of delivering a liquid medicine from such an injector device. The device comprises a storage chamber (6), for the liquid or the liquid precursor components, comprising a storage barrel (16) with at least a section of substantially constant cross-section, defining a storage chamber axis, and a pressure chamber (4) comprising a pressure barrel (10) of substantially constant cross-section, defining a pressure chamber axis, for accommodation of at least one piston therein and having a front end opening (14) for ejection of the liquid. The pressure chamber being of sufficient strength to sustain the liquid pressure. The chambers are separate parts and adapted to cooperate with each other during injection so that the pressure chamber axis and the storage chamber axis substantially coincide, and that the pressure barrel and storage barrel have internal diameters sufficiently similar to allow passage of a resilient piston from the storage barrel to the pressure barrel in a sealing manner. The liquid is transferred from the storage chamber directly into the delivery chamber when the jet injection is to be performed.
Patent NZ-528917-A (NZ)
Title: Crystalline form of omeprazole
Inventor: HAFNER MILAE NATASA
IPC: A61P1/04
Filed: 2002-04-24
Abstract: Disclosed is omeprazole form C, having the unit cell parameters of: a=9.705-9.740 Angstroms, b=10.335-10.375 Angstroms, c=10.525-10.590 Angstroms, alpha=90.95-91.15°, beta=111.70-111.90°, and gamma =116.25-116.50°. Also disclosed is a process for the preparation of omeprazole form C, comprising: (a) dissolving crude omeprazole in a solvent or a mixture of solvents in which omeprazole is freely soluble, and (b) precipitating omeprazole form C with acetone, in which omeprazole is poorly soluble, wherein adding acid to the solution of omeprazole in the precipitation solvent is excluded.
Patent NZ-529398-A (NZ)
Title: 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives as opiod receptor agonists and their use for the treatment of pain, anxiety or gastrointestinal disorders
Inventor: BROWN WILLIAM
IPC: A61P25/00
Filed: 2002-05-16
Abstract: Disclosed are compounds of formula I and formula X, wherein: R1 is a phenyl or heterocyclic group, which is optionally substituted. Also disclosed are compounds of formula III, wherein PG is a urethane protecting group. The compounds of formula I are used in the manufacture of medicaments for the treatment of pain, anxiety or functional gastrointestinal disorders.
Patent NZ-530318-A (NZ)
Title: Integrated parachute harness system
Inventor: DOUGLAS DAVID JAY
IPC: B64D17/22
Filed: 2002-05-24
Abstract: The disclosed integrated parachute harness system has multiple points of resistance, thereby securing a wearer in three directions. The system further relates to an integrated system including a parachute harness, a survival vest and a flotation collar.
Patent NZ-531026-A (NZ)
Title: Transgenic plants expressing intrinsic factor that binds to cobalamin - aka vitamin B12 - or analogue thereof, methods of isolating and uses in diagnostic tests
Inventor: BERGLUND LARS ERIK
IPC: A23L19/00
Filed: 2002-07-12
Abstract: Described is the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. Also described is the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
Patent NZ-532876-A (NZ)
Title: Methods and compositions for use of (S)-bisoprolol
Inventor: KELLY JOHN
IPC: A61K31/135
Filed: 2002-11-15
Abstract: Disclosed is a solid dosage form comprising a therapeutically effective amount of enriched (S)-bisoprolol. The solid dosage form is used for the manufacture of medicaments for the treatment of one or more cardiovascular conditions, in which the enriched (S)-bisoprolol has lesser side effects than the same amount of racemic bisoprolol.
Patent NZ-534889-A (NZ)
Title: Sauna apparatus including a chamber and heating unit which includes a first and second insulative sheets and a graphite film
Inventor: CHEN CHING-SONG
Filed: 2004-08-23
Abstract: A sauna 2 includes a heating unit and a housing that defines a chamber having left, right, front and rear walls interconnected by a floor and ceiling. The heating unit includes at least one sheet-type heating element 3 attached to the walls, ceiling or floor. The heating element includes first and second insulating sheets (32, figure 3) and a graphite film (31, figure 3). The first and second sheets 32 are connected and stacked one above the other, and the graphite film 31 is coated on to one of the first or second sheets and sandwiched between them. The first and second sheets 32 may be made from glass fibre, and the heating element 3 may have a thickness of less than 1/25 inch.
Patent NZ-537562-A (NZ)
Title: Processes for the treatment of residues, by-products and waste materials arising from bauxite refineries
Inventor: MCCONCHIE DAVID
IPC: C01F7/066
Filed: 2003-07-04
Abstract: A process for the treatment of a waste material containing species having a high alkalinity and/or pH is disclosed. The process comprises the steps of contacting the waste material with a first treatment material such as sea water concentrated by evaporation. The amount of the first treatment material is sufficient to cause at least some of the alkaline species to be inactivated, thereby resulting in a treated waste material. The process may also include a step of separating the treated waste material into solid and liquid phases and then contacting the liquid phase with a sufficient amount of a second treatment material having a low pH, so as to cause at least one of the pH and alkalinity of the liquid phase to be reduced to an environmentally acceptable level.
Patent NZ-539479-A (NZ)
Title: Metering device for dispensing precise portions fluid food including a slide piston
Inventor: ASKMAN LARS
IPC: G01F11/22
Filed: 2003-10-22
Abstract: A device for accurately metering food. The device includes an outer part and an inner metering part having a dosing chamber and a piston block slideably mounted therein. The housing outer part has three passageways, and the dosing chamber is configured, dimensioned, and positioned to alternately connect two of the three passageways of the outer part. The inner metering part is configured, dimensioned and positioned for rotation within the outer part. The outer housing part and the inner metering part are mounted concentrically with the inner metering part and the inner metering part has only one degree of liberty in rotation around a central axis of rotation.
Patent NZ-541055-A (NZ)
Title: Modular building unit and method of assembly
Inventor: WINDOW JOHN
IPC: E04B1/348
Filed: 2003-12-03
Abstract: A modular building unit comprising a shell formed from side wall lattice frameworks connected together by cross-beams at floor and ceiling height and end wall lattice frameworks secured to the ends of the resulting structure. The wall lattice frameworks are constructed at a first site where each is formed from an array of mutually parallel spaced structural uprights made from cold-formed structural steel sections, secured together by horizontal or diagonal cross-braces also made from cold-formed structural steel sections. The wall lattice frameworks are build up into the shell at a second site where each of the cross-beams, made from a cold-formed structural steel C-section, is connected to the wall lattice frameworks by being sleeved into or around lateral spur members extending from the wall lattice frameworks prior to being welded thereto.
Patent NZ-544237-A (NZ)
Title: Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
Inventor: FUKUDA YASUMICHI
IPC: C07D413/02
Filed: 2004-06-29
Abstract: Oxazolidinones represent the first new class of antibacterials to be developed since the quinolones. The disclosure relates to new oxazolidinones of general formula I, wherein the variables shown in formula I are as defined in the specification, having a cyclopropyl moiety, which are effective against aerobic and anaerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species, as well as acid-fast organisms such as Mycobacterium tuberculosis and other mycobacterial species.
Patent NZ-544365-A (NZ)
Title: Tablets containing enrofloxacin and flavouring agents and/or aromatizing substances
Inventor: KANIKANTI VENKATA-RANGARAO
IPC: A23L27/26
Filed: 2004-06-14
Abstract: Disclosed is a tablet, comprising by weight 20-45% enrofloxacin, 18-35% lactose, 5-10% microcrystalline cellulose, and 5-20% meat flavour. Also disclosed is a process for producing such a tablet, comprising mixing enrofloxacin, lactose, optionally meat flavour and any additional adjuvants, granulating the mixture in the added presence of water or aqueous solutions of additional adjuvants, drying the mixture, admixing microcrystalline cellulose, any additional adjuvants, and meat flavour if this has not already been added, and pressing the mixture into tablets.
Patent NZ-548229-A (NZ)
Title: Integrase fusion proteins and their use with integrating gene therapy
Inventor: AHLROTH MERVI
IPC: C12N15/867
Filed: 2005-01-14
Abstract: Disclosed is an in vitro method of targeting integration of a transgene comprising retrovirus-like nucleic acid into a eukaryotic genome, in which the genome is targeted by a restriction enzyme that bind nucleic acid and the transgene is introduced at the binding site, wherein the endonuclease is specific to a site in an abundant rDNA locus and is fused to an integrase that mediates the introduction of the transgene.
Patent NZ-549526-A (NZ)
Title: Human skin equivalents comprising near diploid immortalized keratinocyte cells (NIKS)
Inventor: COMER ALLEN
IPC: C12Q1/68
Filed: 2002-03-01
Abstract: Disclosed is a composition comprising a pre-graft human skin equivalent, said skin equivalent having a surface electrical capacitance of from about 40 to about 240 pF measured as the difference in reading over a 10 second interval, said skin equivalent having a combined content of ceramides 5, 6, and 7 in said skin equivalent of from about 20 to about 50% of total ceramide content, wherein said pre-graft skin equivalent comprises Near Diploid Immortalized Keratinocyte cells, and a method of screening for cellular toxicity using said skin equivalent.
Patent NZ-550482-A (NZ)
Title: Use of peptidic compounds for the prophylaxis and treatment of chronic headache
Inventor: SCHELLER DIETER
IPC: A61K31/16
Filed: 2005-04-15
Abstract: Disclosed is the use of a compound having the Formula (IIb) wherein Ar is phenyl which is unsubstituted or substituted with at least one halo group; R3 is CH2-Q, wherein Q is alkoxy containing 1-6 carbon atoms, and R1 is alkyl containing 1-6 carbon atoms or of a pharmaceutically acceptable salt thereof, for the preparation of a pharmaceutical composition for the prevention of migraine.
Patent NZ-550815-A (NZ)
Title: Method of improving T cell receptors
Inventor: DUNN STEVEN MARK
IPC: G01N33/68
Filed: 2005-05-10
Abstract: Disclosed is a method of increasing the affinity and/or decreasing the off-rate of a given TCR specific for a given target pMHC, comprising creating a plurality of TCRs having an alpha chain CDR2 sequence and/or a beta chain CDR2 sequence different from the corresponding CDR2 sequence(s) of the given TCR but having the same alpha and beta CDR1 and CDR3 sequences as the given TCR, determining the affinity and/or off-rate of members of said plurality of TCRs for the target pMHC, and selecting one or more members having at least a 10-fold greater affinity for the target pMHC than the given TCR and/or a 10-fold slower off-rate for the target pMHC than the given TCR.
Patent NZ-553539-A (NZ)
Title: A diphenylmethyl piperazine derivative and its use as a delta agonist for treating pain, anxiety, and depression
Inventor: BROWN WILLIAM
IPC: A61K31/495
Filed: 2005-07-27
Abstract: Disclosed is the compound of the pictured formula, or a pharmaceutically acceptable salt thereof. Also disclosed is the use of this compound for treating pain, anxiety, and depression.
Patent NZ-563676-A (NZ)
Title: Safflower with elevated gamma-linolenic acid
Inventor: KNAUF VIC C
IPC: A23L33/00
Filed: 2006-05-22
Abstract: Provided is a transgenic safflower plant comprising a recombinant promoter functional in said safflower plant wherein said promoter is operably linked to a recombinant DNA sequence encoding a delta 6 desaturase, wherein said safflower plant produces seeds and said seeds comprise gamma-linolenic acid (GLA) at a level of at least 40% by weight of the total fatty acid content of said seeds. Further provided is seeds and oil produced by such plants.
Patent NZ-563777-A (NZ)
Title: Serine protease derived from Bacillus licheniformis optionally in combination with lipases and amylases for pharmaceutical use
Inventor: SVENDSEN ALLAN
IPC: A61K38/48
Filed: 2006-06-16
Abstract: The pharmaceutical use of protease having 70% sequence identity to amino acids 1-274 of SEQ ID NO: 2, the serine protease derived from Bacillus licheniformis, which is also designated subtilisin Carlsberg, optionally in combination with a lipase and/or amylase for treatment of pancreatic exocrine insufficiency.
Patent NZ-572072-A (NZ)
Title: Inhibitors of c-fms kinase
Inventor: ILLIG CARL R
IPC: C07D405/12
Filed: 2007-04-18
Abstract: Disclosed are phenyl or pyridyl amide compounds of formula (I), or solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, wherein W is an imidazole, pyrrole, triazole or tetrahydrofuran moiety thereof and X is a five or six membered oxygen or oxygen and nitrogen containing ring. Also disclosed is the use of the compounds of formula (I) for treating cancer, inflammation, pain, cardiovascular diseases and the like.